| Financial Year |
March 31 2023 |
| Monetary Funds |
606,247,538.15 |
| Held-for-trading Financial Assets |
230,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
205,867,628.68 |
| Advances to Suppliers |
179,262,221.08 |
| Other Receivables |
118,211,284.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
123,917,294.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,193,567.02 |
| Total Current Assets |
1,504,699,533.60 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
118,363,367.47 |
| Investment Properties |
-- |
| Fixed Assetes |
714,270,232.31 |
| Under-construction Projects |
19,250,306.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,087,535.54 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
559,820,428.92 |
| Deferred Income Tax Assets |
178,698,806.78 |
| Other Non-Current Assets |
49,928,830.16 |
| Sub-Total of Non-Current Assets |
3,186,695,827.14 |
| Total Assets |
4,691,395,360.74 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
415,166,782.29 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,705,224.17 |
| Taxes Payable |
15,310,399.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,720,700.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
288,819,152.73 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
1,359,768,430.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
4,018,075.50 |
| Deferred Income Tax Liabilities |
649,051.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,007,970,642.11 |
| Total Liabilities |
3,367,739,072.72 |
| Paid-In Capital(Or Share Stock) |
634,200,000.00 |
| Capital Surplus |
568,561,432.32 |
| Surplus Reserve |
146,851,653.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-25,956,797.57 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,323,656,288.02 |
| Owner's Equity（Stockholder's Equity） |
1,323,656,288.02 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,691,395,360.74 |
